Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Amyloid ß Fibril Disruption by Oleuropein Aglycone: Long-Time Molecular Dynamics Simulation to Gain Insight Into the Mechanism of Action of This Polyphenol From Extra Virgin Olive Oil Publisher Pubmed



Brogi S1 ; Sirous H2 ; Calderone V1 ; Chemi G3
Authors

Source: Food and Function Published:2020


Abstract

In the central nervous system (CNS), extra virgin olive oil (EVOO) produces interesting effects against neurodegenerative disorders including Alzheimer's disease (AD). The valuable properties of EVOO are largely ascribed to oleuropein aglycone (OA), its most abundant phenolic constituent. In particular, it has been demonstrated that in AD, OA produces strong neuroprotective effects being able to reduce amyloid ß (Aß) aggregates, thereby diminishing the related cytotoxicity and inflammation. OA prevents Aß aggregation, but more importantly OA was able to disrupt the preformed Aß fibrils. Herein, we describe a comprehensive computational investigation of the mechanism of action of OA as an Aß fibril disruptor at the molecular level. We employed extensive molecular docking calculations and long-time molecular dynamics simulation for mimicking the system of OA/Aß fibrils. The results showed that OA is able to move in depth within the Aß fibrils targeting a key motif in Aß peptide, known to be relevant for stabilizing the assembled fibrils. OA causes a structural instability of preformed Aß fibrils, determining the effective Aß fibril disaggregation. Accordingly, this study highlighted the role of OA as a potent anti-amyloidogenic drug. On the other hand, our work has relevant implications for rationally designing potent multifunctional compounds acting as disease modifying anti-Alzheimer's drugs for the development of innovative anti-AD therapeutics. © 2020 The Royal Society of Chemistry.
Related Docs
View other Related Docs
1. Identification of Novel 3-Hydroxy-Pyran-4-One Derivatives As Potent Hiv-1 Integrase Inhibitors Using in Silico Structure-Based Combinatorial Library Design Approach, Frontiers in Chemistry (2019)
2. Discovery of Novel Hit Compounds As Potential Hdac1 Inhibitors: The Case of Ligand- and Structure-Based Virtual Screening, Computers in Biology and Medicine (2021)
3. In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile, Computation (2023)
Experts (# of related papers)
View all Related Experts
Afshin Fassihi (5)
Lotfollah Saghaie Dehkordi (3)
Other Related Docs
4. Disruption of Irisin Dimerization by Fda-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes, International Journal of Molecular Sciences (2023)
5. Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel Sars-Cov-2 Nsp3 Mac1 Domain Inhibitors, Viruses (2023)
6. Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment, Future Medicinal Chemistry (2023)
7. Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors, Molecules (2020)
8. Preparing a Database of Corrected Protein Structures Important in Cell Signaling Pathways, Research in Pharmaceutical Sciences (2023)
9. An Integrated in Silico Screening Strategy for Identifying Promising Disruptors of P53-Mdm2 Interaction, Computational Biology and Chemistry (2019)
10. Combining Subtractive Genomics With Computer-Aided Drug Discovery Techniques to Effectively Target S. Sputigena in Periodontitis, Computation (2025)
11. Discovery of Novel Direct Small-Molecule Inhibitors Targeting Hif-2Α Using Structure-Based Virtual Screening, Molecular Dynamics Simulation, and Mm-Gbsa Calculations, Molecular Diversity (2024)
12. Synthesis, Molecular Modelling and Biological Studies of 3-Hydroxy-Pyrane-4-One and 3-Hydroxy-Pyridine-4-One Derivatives As Hiv-1 Integrase Inhibitors, Medicinal Chemistry (2019)
13. An In-Silico Screening Strategy to the Prediction of New Inhibitors of Covid-19 Mpro Protein, Iranian Journal of Pharmaceutical Research (2021)
14. Identification of New Small Molecules As Dual Foxm1 and Hsp70 Inhibitors Using Computational Methods, Research in Pharmaceutical Sciences (2022)
15. Exosomes As Efficient Platforms for Delivering Adenosine-Tetra Peptide Conjugate to Pancreatic Cancer Cells: An in Vitro/In Silico Study, Journal of Drug Delivery Science and Technology (2023)
16. Pharmacological Activities and Molecular Mechanisms of Sinapic Acid in Neurological Disorders, ACS Chemical Neuroscience (2024)
17. Neuroprotective Effects of Flavonoids, Phytonutrients and Neurological Disorders: Therapeutic and Toxicological Aspects (2023)
18. Molecular Docking and Quantum Mechanical Studies on Biflavonoid Structures As Bace-1 Inhibitors, Structural Chemistry (2015)
19. Gp41 Inhibitory Activity Prediction of Theaflavin Derivatives Using Ligand/Structure-Based Virtual Screening Approaches, Computational Biology and Chemistry (2019)
20. Identification of Cholinesterases Inhibitors From Flavonoids Derivatives for Possible Treatment of Alzheimer's Disease: In Silico and in Vitro Approaches, Current Research in Structural Biology (2024)